DoorDash, Inc. Class A Common Stock (DASH)vsMEDIFAST INC (MED)
DASH
DoorDash, Inc. Class A Common Stock
$168.65
-0.40%
CONSUMER CYCLICAL · Cap: $73.49B
MED
MEDIFAST INC
$10.87
-0.46%
CONSUMER CYCLICAL · Cap: $118.70M
Smart Verdict
WallStSmart Research — data-driven comparison
DoorDash, Inc. Class A Common Stock generates 3456% more annual revenue ($13.72B vs $385.79M). DASH leads profitability with a 6.8% profit margin vs -4.8%. MED appears more attractively valued with a PEG of 0.97. DASH earns a higher WallStSmart Score of 59/100 (C).
DASH
Buy59
out of 100
Grade: C
MED
Hold45
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+3.0%
Fair Value
$180.89
Current Price
$168.65
$12.24 discount
Intrinsic value data unavailable for MED.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 37.7% year-over-year
Large-cap with strong market position
Earnings expanding 47.7% YoY
Reasonable price relative to book value
Safe zone — low bankruptcy risk
Growing faster than its price suggests
Areas to Watch
Expensive relative to growth rate
Grey zone — moderate risk
6.8% margin — thin
Premium valuation, high expectations priced in
Smaller company, higher risk/reward
Weak financial health signals
ROE of -9.1% — below average capital efficiency
Revenue declined 36.9%
Comparative Analysis Report
WallStSmart ResearchBull Case : DASH
The strongest argument for DASH centers on Revenue Growth, Market Cap, EPS Growth. Revenue growth of 37.7% demonstrates continued momentum.
Bull Case : MED
The strongest argument for MED centers on Price/Book, Altman Z-Score, PEG Ratio. PEG of 0.97 suggests the stock is reasonably priced for its growth.
Bear Case : DASH
The primary concerns for DASH are PEG Ratio, Altman Z-Score, Profit Margin. A P/E of 79.5x leaves little room for execution misses.
Bear Case : MED
The primary concerns for MED are Market Cap, Piotroski F-Score, Return on Equity.
Key Dynamics to Monitor
DASH profiles as a hypergrowth stock while MED is a turnaround play — different risk/reward profiles.
DASH carries more volatility with a beta of 1.93 — expect wider price swings.
DASH is growing revenue faster at 37.7% — sustainability is the question.
DASH generates stronger free cash flow (254M), providing more financial flexibility.
Bottom Line
DASH scores higher overall (59/100 vs 45/100) and 37.7% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
DoorDash, Inc. Class A Common Stock
CONSUMER CYCLICAL · INTERNET RETAIL · USA
DoorDash, Inc. operates a logistics platform that connects merchants, consumers, and merchants in the United States and internationally. The company is headquartered in San Francisco, California.
Visit Website →MEDIFAST INC
CONSUMER CYCLICAL · PERSONAL SERVICES · USA
Medifast, Inc. manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutrition products in the United States and Asia-Pacific. The company is headquartered in Baltimore, Maryland.
Visit Website →Compare with Other INTERNET RETAIL Stocks
Want to dig deeper into these stocks?